Search research articles
Contact Us
Filters
Showing results (101-110 of 157) with videos related to
Page
of 16
Sort By:
Chinese Clinical Oncology
|
September 2, 2025
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?-a narrative review
Fabrizio Di Costanzo, Iolanda Santa Parisi, Giuseppe Neola, et al.
The Oncologist
|
May 16, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer
Vincenza Conteduca, Emanuela Scarpi, Alice Rossi, et al.
International Journal of Cancer
|
October 4, 2021
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients
Vincenza Conteduca, Emanuela Scarpi, Daniel Wetterskog, et al.
NPJ Precision Oncology
|
September 13, 2023
Evolution of structural rearrangements in prostate cancer intracranial metastases
Francesca Khani, William F Hooper, Xiaofei Wang, et al.
European Urology Oncology
|
June 22, 2025
Epidemiology of High-risk Biochemical Recurrence After Primary Prostate Cancer Treatment
Ugo Giovanni Falagario, Francesco Pellegrino, Lars Björnebo, et al.
Clinical Genitourinary Cancer
|
July 19, 2024
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
Marzia Del Re, Stefania Crucitta, Nicole Brighi, et al.
The Journal of Clinical Investigation
|
February 25, 2020
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer
Himisha Beltran, Alessandro Romanel, Vincenza Conteduca, et al.
Scientific Reports
|
July 2, 2025
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA
Alessandra Virga, Milena Urbini, Maurizio Polano, et al.
European Urology Oncology
|
July 11, 2025
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis
Fabiano Flauto, Giuseppe Neola, Carmine Caso, et al.
Future Oncology (London, England)
|
September 13, 2018
Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program
Francesca Maines, Ugo De Giorgi, Giuseppe Procopio, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 157) with videos related to
Sort By:
Page
of 16
Chinese Clinical Oncology
|
September 2, 2025
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?-a narrative review
Fabrizio Di Costanzo, Iolanda Santa Parisi, Giuseppe Neola, et al.
The Oncologist
|
May 16, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer
Vincenza Conteduca, Emanuela Scarpi, Alice Rossi, et al.
International Journal of Cancer
|
October 4, 2021
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients
Vincenza Conteduca, Emanuela Scarpi, Daniel Wetterskog, et al.
NPJ Precision Oncology
|
September 13, 2023
Evolution of structural rearrangements in prostate cancer intracranial metastases
Francesca Khani, William F Hooper, Xiaofei Wang, et al.
European Urology Oncology
|
June 22, 2025
Epidemiology of High-risk Biochemical Recurrence After Primary Prostate Cancer Treatment
Ugo Giovanni Falagario, Francesco Pellegrino, Lars Björnebo, et al.
Clinical Genitourinary Cancer
|
July 19, 2024
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
Marzia Del Re, Stefania Crucitta, Nicole Brighi, et al.
The Journal of Clinical Investigation
|
February 25, 2020
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer
Himisha Beltran, Alessandro Romanel, Vincenza Conteduca, et al.
Scientific Reports
|
July 2, 2025
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA
Alessandra Virga, Milena Urbini, Maurizio Polano, et al.
European Urology Oncology
|
July 11, 2025
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis
Fabiano Flauto, Giuseppe Neola, Carmine Caso, et al.
Future Oncology (London, England)
|
September 13, 2018
Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program
Francesca Maines, Ugo De Giorgi, Giuseppe Procopio, et al.
Page
of 16